Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
30.30
-1.42 (-4.48%)
At close: May 14, 2026, 4:00 PM EDT
30.50
+0.20 (0.66%)
After-hours: May 14, 2026, 6:40 PM EDT

Assembly Biosciences Market Cap

Assembly Biosciences has a market cap or net worth of $481.55 million as of May 14, 2026. Its market cap has increased by 463.21% in one year.

Market Cap
481.55M
Enterprise Value
257.44M
1-Year Change
463.21%
Ranking
Category
Stock Price
$30.30

Market Cap Chart

Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $481.55M, an increase of 1,097.88%. That is a compound annual growth rate of 17.48%.

History

DateMarket Cap% Change
May 14, 2026481.50M-10.49%
Dec 31, 2025537.90M436.29%
Dec 31, 2024100.30M86.09%
Dec 29, 202353.90M-14.98%
Dec 30, 202263.40M-43.14%
Dec 31, 2021111.50M-44.19%
Dec 31, 2020199.80M-62.51%
Dec 31, 2019532.90M-7.48%
Dec 31, 2018576.00M-26.83%
Dec 29, 2017787.20M276.11%
Dec 30, 2016209.30M61.75%
Dec 31, 2015129.40M54.60%
Dec 31, 201483.70M5.02%
Dec 31, 201379.70M185.66%
Dec 31, 201227.90M-71.93%
Dec 30, 201199.40M135.55%
Dec 31, 201042.20M4.98%
Dec 17, 201040.20M-
View and export this data all the way back to 2010. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Contineum Therapeutics510.70M
Shattuck Labs500.35M
XOMA Royalty497.96M
Ocugen497.62M
Ovid Therapeutics496.62M
Prothena Corporation493.69M
Neurogene492.52M
Upstream Bio486.51M
Market Cap Rankings